UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) October 12, 2012

 

 

FUSE SCIENCE, INC.

(Exact Name of Registrant as Specified in Charter)  

 

Nevada

(State or Other Jurisdiction

of Incorporation)

 

     
000-22991   87-0460247

(Commission

File Number)

 

 

(IRS Employer

Identification No.)

 

   

6135 NW 167th Street, #E-21

Miami Lakes, Florida

  33015
(Address of Principal Executive Offices)   (Zip Code)

(305) 503-3873

(Registrant’s telephone number, Including Area Code)

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 8.01 Other Events

 

On October 12, 2012, Fuse Science, Inc. (“Fuse”) borrowed $250,000 from a third party (the “Subordinated Loan”). The Subordinated Loan is evidenced by a $250,000 promissory note bearing interest at the rate of 9% per annum (the “Note”). The Note is payable on demand, is subordinated to all present and future senior indebtedness (as defined therein), is unsecured and is not convertible into shares of Fuse common stock.

 

The proceeds of the Loan will be used for working capital and other general corporate purposes.

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

FUSE SCIENCE, INC.

 

By:  /s/ Brian Tuffin                                                                                          

Brian Tuffin

Chief Executive Officer and Acting Chief Financial Officer

 

Dated: October 15, 2012